Evidence map›Paper›PMID 28523273›Full record

ReviewBioMed research international2017

Novel

Aleksey Kubanov, Anastassia Runina, Dmitry Deryabin

Open access · hybridAbstract readReview
In one paragraph

Review in BioMed research international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Participants inFrontiers in immunology · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. PCR detection for syphilis diagnosis: Status and prospects.Journal of clinical laboratory analysis · 2019
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Aleksey KubanovDepartment of Laboratory Diagnostics of Sexually Transmitted Diseases and Dermatoses, State Research Center of Dermatovenereology and Cosmetology, Korolenko Street 3/6, Moscow 107076, Russia.
Anastassia RuninaDepartment of Laboratory Diagnostics of Sexually Transmitted Diseases and Dermatoses, State Research Center of Dermatovenereology and Cosmetology, Korolenko Street 3/6, Moscow 107076, Russia.
Dmitry DeryabinDepartment of Laboratory Diagnostics of Sexually Transmitted Diseases and Dermatoses, State Research Center of Dermatovenereology and Cosmetology, Korolenko Street 3/6, Moscow 107076, Russia.ORCID 0000-0002-9578-7947
State Research Center for Dermatovenereology and Cosmetology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recombinant protein technology considerably promoted the development of rapid and accurate treponema-specific laboratory diagnostics of syphilis infection. For the last ten years, the immunodominant recombinant inner membrane lipoproteins are proved to be sensitive and specific antigens for syphilis screening. However, the development of an enlarged

Indexed as

Antigens, BacterialBacterial ProteinsHumansRecombinant ProteinsSyphilisSyphilis SerodiagnosisTreponema pallidumAntigens, BacterialBacterial ProteinsRecombinant Proteins

Identifiers

PMID28523273
PMCPMC5421087
OpenAlexW2610144132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.